Skip to main content

Advertisement

Log in

Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Introduction

Fast spin-echo (FSE) T1-weighted (T1W) magnetic resonance imaging (MRI) at 3T, which is sensitive to neuromelanin-related contrast, can quantitatively detect signal alterations in the locus ceruleus (LC) and the substantia nigra pars compacta (SNc) of depressive and schizophrenic patients; however, its qualitative diagnostic performance remains unknown. We investigated whether visual interpretation of semiquantitative color maps can be used for discriminating between depressive and schizophrenic patients and healthy individuals.

Methods

We retrospectively examined 23 patients with major depression, 23 patients with schizophrenia, and 23 age-matched healthy controls by using a FSE-T1W MRI technique. Semiquantitative color maps of sections through the LC and SNc were visually interpreted by nine raters using a continuous confidence rating scale for receiver operating characteristic (ROC) analysis.

Results

The area under the ROC curve (Az), which reflects the performance in differentiating between depressive patients and controls, was 0.88, and the sensitivity and specificity at the maximum likelihood were 76% and 83%, respectively. In contrast, the Az value, sensitivity, and specificity values between schizophrenics and controls and between depressives and schizophrenics were 0.66 and 0.69, 42% and 48%, and 82% and 84%, respectively.

Conclusion

Semiquantitative, color-coded FSE-T1W MRI at 3T can be used for visually differentiating depressive patients from healthy individuals with a substantially high likelihood, but this technique cannot be applied to distinguish schizophrenic patients from the other two groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sasaki M, Shibata E, Tohyama K, Takahashi J, Otsuka K, Tsuchiya K, Takahashi S, Ehara S, Terayama Y, Sakai A (2006) Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson’s disease. NeuroReport 31:1215–1218

    Article  Google Scholar 

  2. Shibata E, Sasaki M, Tohyama K, Otsuka K, Sakai A et al (2007) Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging. NeuroReport 18:415–418

    Article  PubMed  Google Scholar 

  3. Shibata E, Sasaki M, Tohyama K, Otsuka K, Endoh J, Terayama Y, Sakai A (2008) Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus. Biol Psychiatry 64:401–406

    Article  CAS  PubMed  Google Scholar 

  4. ASIST-Japan recommended standard LUT (a-LUT) for perfusion color maps. Acute Stroke Imaging Standardization Group Japan Web site. http://asist.umin.jp/index-e.htm. Published July 9, 2005. Updated September 22, 2007. Accessed July 15, 2009

  5. Metz CE, Herman BA, Shen JH (1998) Maximum-likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. Stat Med 17:1033–1053

    Article  CAS  PubMed  Google Scholar 

  6. Konarski JZ, McIntyre RS (2007) Soczynska JK (2007) Neuroimaging approaches in mood disorders: technique and clinical implications. Ann Clin Psychiatry 19:265–277

    Article  PubMed  Google Scholar 

  7. McKinnon MC, Yucel K, Nazarov A, MacQueen GM (2009) A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 34:41–54

    PubMed  Google Scholar 

  8. Zipursky RB, Meyer JH, Verhoeff NP (2007) PET and SPECT imaging in psychiatric disorders. Can J Psychiatry 52:146–157

    PubMed  Google Scholar 

  9. Steele JD, Bastin ME, Wardlaw JM, Ebmeier KP (2005) Possible structural abnormality of the brainstem in unipolar depressive illness: a transcranial ultrasound and diffusion tensor magnetic resonance imaging study. J Neurol Neurosurg Psychiary 76:1510–1515

    Article  CAS  Google Scholar 

  10. Supprian T, Reiche W, Schmitz B, Grunwald I, Backens M, Hofmann E, Georg T, Falkai P, Reith W (2004) MRI of the brainstem in patients with major depression, bipolar affective disorder and normal controls. Psychiatry Res 131:269–276

    Article  PubMed  Google Scholar 

  11. Graham DG (1979) On the origin and significance of neuromelanin. Arch Pathol Lab Med 103:359–362

    CAS  PubMed  Google Scholar 

  12. Van Woert MH, Ambani LM (1974) Biochemistry of neuromelanin. Adv Neurol 5:215–223

    PubMed  Google Scholar 

  13. Enochs WS, Petherick P, Bogdanova A, Mohr U, Weissleder R (1997) Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204:417–423

    CAS  PubMed  Google Scholar 

  14. Tosk JM, Holshouser BA, Aloia RC, Hinshaw DB Jr, Hasso AN, MacMurray JP, Will AD, Bozzetti LP (1992) Effects of the interaction between ferric iron and L-dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn Reson Med 26:40–45

    Article  CAS  PubMed  Google Scholar 

  15. Baumann B, Danos P, Krell D, Diekmann S, Wurthmann C, Bielau H, Bernstein HG, Bogerts B (1999) Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 54:217–224

    Article  CAS  PubMed  Google Scholar 

  16. Priddle CRM, Crow TH, TJ EMM (2005) The locus coeruleus in schizophrenia: a postmortem study of noradrenergic neurons. Neuropathol Appl Neurobiol 31:115–126

    Article  PubMed  Google Scholar 

  17. Bogerts B, Hantsch J, Herzer M (1983) A morphometric study of the dopamine-containing cell groups in the mecencephalon of normals, Parkinson patients, and schizophrenics. Biol Psychiatry 18:951–969

    CAS  PubMed  Google Scholar 

  18. Kaiya H (1980) Neuromelanin, neuroleptics and schizophrenia: hypothesis of an interaction between noradrenergic and dopaminergic system. Neuropsychobiology 6:241–248

    Article  CAS  PubMed  Google Scholar 

  19. van Kammen DP, Kelley M (1991) Dopamine and norepinephrine activity in schizophrenia. An integrative perspective. Schizophr Res 4:173–191

    Article  PubMed  Google Scholar 

  20. Casanova MF, Comparini SO, Kim RW, Kleinman JE (1992) Staining intensity of brain iron in patients with schizophrenia: a postmortem study. J Neuropsychiatry Clin Neurosci 4:36–41

    CAS  PubMed  Google Scholar 

  21. Shibata E, Sasaki M, Tohyama K, Kanbara Y, Otsuka K, Ehara S, Sakai A (2006) Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci 5:197–200

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was partly supported by a Grant-in-Aid for Strategic Medical Science Research Center and a Grant-in-Aid for Science Research (20591458) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.

Conflict of interest statement

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Makoto Sasaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sasaki, M., Shibata, E., Ohtsuka, K. et al. Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging. Neuroradiology 52, 83–89 (2010). https://doi.org/10.1007/s00234-009-0595-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-009-0595-7

Keywords

Navigation